Note: Ingredients listed on restricted chemical lists
EC/CAS
111-42-2
Name of the chemical
N,N-Diethanolamine (Ethanol, 2,2'-iminobis-)
Concentration
N/A
General Information
Revision date
2009-10-06
Product name
ECF Substrate Dilution Buffer; part of "ECF
CAS No.
111-42-2
supplier name
GE Healthcare UK Ltd
Emergency telephone
1-800-424-9300
Icons in SDS
Company Information
company name
GE Healthcare UK Ltd
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
This material is considered hazardous by the OSHA Hazard Communication Standard ( 29 CFR 1910. 1200 ) Physical state Liquid. Odor Not available. OSHA/HCS status This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200). Emergency overview WARNING! CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION. MAY BE HARMFUL IF SWALLOWED. CONTAINS MATERIAL THAT MAY CAUSE TARGET ORGAN DAMAGE, BASED ON ANIMAL DATA.
Precautionary statements
Do not breathe vapor or mist. Do not ingest. Use only with adequate ventilation. Do not eat, drink or smoke when using this product. Avoid contact with eyes, skin and clothing. Keep container tightly closed. Wash thoroughly after handling. Routes of entry Dermal contact. Eye contact. Inhalation. Ingestion.
Potential Acute Health Effects
Eyes Severely irritating to eyes. Risk of serious damage to eyes. Skin Irritating to skin. Inhalation Irritating to respiratory system. Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. Ingestion Harmful if swallowed.
Potential chronic health
effects Contains material that may cause target organ damage, based on animal data. Carcinogenicity No known significant effects or critical hazards. Mutagenicity No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects No known significant effects or critical hazards. Fertility effects No known significant effects or critical hazards. Target organs Contains material which may cause damage to the following organs: kidneys, liver, upper respiratory tract, skin, eyes. Inhalation Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion No specific data. Skin Adverse symptoms may include the following: irritation redness Eyes Adverse symptoms may include the following: pain or irritation watering redness
Medical Conditions Generally Aggravated by Exposure
Pre-existing disorders involving any target organs mentioned in this MSDS as being at risk may be over-exposure aggravated by over-exposure to this product. See toxicological information (Section 11)
